Serum Transthyretin: Predictor of Amyloidosis Outcomes?
Circ Heart Fail
.
2018 Feb;11(2):e004802.
doi: 10.1161/CIRCHEARTFAILURE.118.004802.
Author
Jose Nativi-Nicolau
1
Affiliation
1
From the Cardiac Amyloidosis Program, University of Utah Health Sciences Center and Huntsman Cancer Institute, Salt Lake City. jose.nativi@hsc.utah.edu.
PMID:
29449369
DOI:
10.1161/CIRCHEARTFAILURE.118.004802
No abstract available
Keywords:
Editorials; amyloid; biomarker; prevalence; risk factor; transthyretin.
Publication types
Editorial
Comment
MeSH terms
Amyloidosis*
Heart Failure*
Humans
Prealbumin
Prognosis
Substances
Prealbumin